BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 17060558)

  • 21. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Of Energy and Entropy: The Ineluctable Impact of Aging in Old Age Dementia.
    Boccardi V; Comanducci C; Baroni M; Mecocci P
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29232829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain mitochondria as a primary target in the development of treatment strategies for Alzheimer disease.
    Aliev G; Palacios HH; Walrafen B; Lipsitt AE; Obrenovich ME; Morales L
    Int J Biochem Cell Biol; 2009 Oct; 41(10):1989-2004. PubMed ID: 19703659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The basis for disease-modifying treatments for Alzheimer's disease: the Sixth Annual Mild Cognitive Impairment Symposium.
    Duara R; Barker W; Loewenstein D; Bain L
    Alzheimers Dement; 2009 Jan; 5(1):66-74. PubMed ID: 19118811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intranasal insulin improves cognition and modulates beta-amyloid in early AD.
    Reger MA; Watson GS; Green PS; Wilkinson CW; Baker LD; Cholerton B; Fishel MA; Plymate SR; Breitner JC; DeGroodt W; Mehta P; Craft S
    Neurology; 2008 Feb; 70(6):440-8. PubMed ID: 17942819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Olfactory tau pathology in Alzheimer disease and mild cognitive impairment.
    Attems J; Jellinger KA
    Clin Neuropathol; 2006; 25(6):265-71. PubMed ID: 17140156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nature or nurture: education and the trajectory of declining brain function with age and Alzheimer disease.
    Drachman DA
    Neurology; 2008 May; 70(19 Pt 2):1725-7. PubMed ID: 18458213
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunity and neuronal repair in the progression of Alzheimer's disease: a brief overview.
    Baron R; Harpaz I; Nemirovsky A; Cohen H; Monsonego A
    Exp Gerontol; 2007; 42(1-2):64-9. PubMed ID: 17074458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytoskeletal alterations differentiate presenilin-1 and sporadic Alzheimer's disease.
    Woodhouse A; Shepherd CE; Sokolova A; Carroll VL; King AE; Halliday GM; Dickson TC; Vickers JC
    Acta Neuropathol; 2009 Jan; 117(1):19-29. PubMed ID: 19015863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regions with different evoked frequency band responses during early-stage visual processing distinguish mild Alzheimer dementia from mild cognitive impairment and normal aging.
    Haupt M; González-Hernández JA; Scherbaum WA
    Neurosci Lett; 2008 Sep; 442(3):273-8. PubMed ID: 18634853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognitive reserve and Alzheimer disease.
    Stern Y
    Alzheimer Dis Assoc Disord; 2006; 20(2):112-7. PubMed ID: 16772747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Slowing the progression of Alzheimer disease: monitoring progression.
    Rossor MN; Fox NC; Freeborough PA; Roques PK
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 5():S6-9. PubMed ID: 9348422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alzheimer's disease and the aging brain.
    Terry RD
    J Geriatr Psychiatry Neurol; 2006 Sep; 19(3):125-8. PubMed ID: 16880353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuro-modulation, aminergic neuro-disinhibition and neuro-degeneration. Draft of a comprehensive theory for Alzheimer disease.
    Schmitt HP
    Med Hypotheses; 2005; 65(6):1106-19. PubMed ID: 16125326
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is early-onset Alzheimer disease a distinct subgroup within the Alzheimer disease population?
    Raskind MA; Carta A; Bravi D
    Alzheimer Dis Assoc Disord; 1995; 9 Suppl 1():S2-6. PubMed ID: 7546596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apolipoprotein E, a gene with complex biological interactions in the aging brain.
    Roses AD
    Neurobiol Dis; 1997; 4(3-4):170-85. PubMed ID: 9361294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stereologic analysis of microvascular morphology in the elderly: Alzheimer disease pathology and cognitive status.
    Bouras C; Kövari E; Herrmann FR; Rivara CB; Bailey TL; von Gunten A; Hof PR; Giannakopoulos P
    J Neuropathol Exp Neurol; 2006 Mar; 65(3):235-44. PubMed ID: 16651885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aging-dependent changes of microglial cells and their relevance for neurodegenerative disorders.
    von Bernhardi R; Tichauer JE; Eugenín J
    J Neurochem; 2010 Mar; 112(5):1099-114. PubMed ID: 20002526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain Aging and Late-Onset Alzheimer's Disease: A Matter of Increased Amyloid or Reduced Energy?
    Mecocci P; Baroni M; Senin U; Boccardi V
    J Alzheimers Dis; 2018; 64(s1):S397-S404. PubMed ID: 29562513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurochemical aspects on aging and diseases with cognitive impairment.
    Gottfries CG
    J Neurosci Res; 1990 Dec; 27(4):541-7. PubMed ID: 2079715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.